260 related articles for article (PubMed ID: 28006972)
21. A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults.
Gray KM; Sonne SC; McClure EA; Ghitza UE; Matthews AG; McRae-Clark AL; Carroll KM; Potter JS; Wiest K; Mooney LJ; Hasson A; Walsh SL; Lofwall MR; Babalonis S; Lindblad RW; Sparenborg S; Wahle A; King JS; Baker NL; Tomko RL; Haynes LF; Vandrey RG; Levin FR
Drug Alcohol Depend; 2017 Aug; 177():249-257. PubMed ID: 28623823
[TBL] [Abstract][Full Text] [Related]
22. A Study of the Impact of Cannabis on Doses of Discharge Antipsychotic Medication in Individuals with Schizophrenia or Schizoaffective Disorder.
Babatope T; Chotalia J; Elkhatib R; Mohite S; Shah J; Goddu S; Patel RA; Aimienwanu OR; Patel D; Makanjuola T; Okusaga OO
Psychiatr Q; 2016 Dec; 87(4):729-737. PubMed ID: 26875104
[TBL] [Abstract][Full Text] [Related]
23. Associations between state-level policy liberalism, cannabis use, and cannabis use disorder from 2004 to 2012: Looking beyond medical cannabis law status.
Philbin MM; Mauro PM; Santaella-Tenorio J; Mauro CM; Kinnard EN; Cerdá M; Martins SS
Int J Drug Policy; 2019 Mar; 65():97-103. PubMed ID: 30685092
[TBL] [Abstract][Full Text] [Related]
24. Higher average potency across the United States is associated with progression to first cannabis use disorder symptom.
Arterberry BJ; Treloar Padovano H; Foster KT; Zucker RA; Hicks BM
Drug Alcohol Depend; 2019 Feb; 195():186-192. PubMed ID: 30573162
[TBL] [Abstract][Full Text] [Related]
25. The association between lifetime cannabis use and dysthymia across six birth decades.
Livne O; Razon L; Rehm J; Hasin DS; Lev-Ran S
J Affect Disord; 2018 Jul; 234():327-334. PubMed ID: 29605793
[TBL] [Abstract][Full Text] [Related]
26. Changes in cannabis use among young people: impact on mental health.
Copeland J; Rooke S; Swift W
Curr Opin Psychiatry; 2013 Jul; 26(4):325-9. PubMed ID: 23689549
[TBL] [Abstract][Full Text] [Related]
27. The association of specific traumatic experiences with cannabis initiation and transition to problem use: Differences between African-American and European-American women.
Werner KB; McCutcheon VV; Agrawal A; Sartor CE; Nelson EC; Heath AC; Bucholz KK
Drug Alcohol Depend; 2016 May; 162():162-9. PubMed ID: 27012434
[TBL] [Abstract][Full Text] [Related]
28. Young adult cannabis use disorder treatment admissions declined as past month cannabis use increased in the U.S.: An analysis of states by year, 2008-2017.
Mennis J; Stahler GJ; McKeon TP
Addict Behav; 2021 Dec; 123():107049. PubMed ID: 34303941
[TBL] [Abstract][Full Text] [Related]
29. Predictive validity of cannabis consumption measures: Results from a national longitudinal study.
Buu A; Hu YH; Pampati S; Arterberry BJ; Lin HC
Addict Behav; 2017 Oct; 73():36-40. PubMed ID: 28463803
[TBL] [Abstract][Full Text] [Related]
30. Associations of PTSD, chronic pain, and their comorbidity on cannabis use disorder: Results from an American nationally representative study.
Bilevicius E; Sommer JL; Asmundson GJG; El-Gabalawy R
Depress Anxiety; 2019 Nov; 36(11):1036-1046. PubMed ID: 31356731
[TBL] [Abstract][Full Text] [Related]
31. Developmental pathways from prenatal marijuana exposure to Cannabis Use Disorder in young adulthood.
Sonon K; Richardson GA; Cornelius J; Kim KH; Day NL
Neurotoxicol Teratol; 2016; 58():46-52. PubMed ID: 27208888
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of Cannabis Use Disorder and Reasons for Use Among Adults in a US State Where Recreational Cannabis Use Is Legal.
Lapham GT; Matson TE; Bobb JF; Luce C; Oliver MM; Hamilton LK; Bradley KA
JAMA Netw Open; 2023 Aug; 6(8):e2328934. PubMed ID: 37642968
[TBL] [Abstract][Full Text] [Related]
33. Self-reported symptoms of cannabis use disorder: Psychometric testing and validation.
Richards DK; Schwebel FJ; Sotelo M; Pearson MR;
Exp Clin Psychopharmacol; 2021 Apr; 29(2):157-165. PubMed ID: 34043399
[TBL] [Abstract][Full Text] [Related]
34. Dimensionality and differential functioning of DSM-5 cannabis use disorder criteria in an online sample of adults with frequent cannabis use.
Shmulewitz D; Budney AJ; Borodovsky JT; Bujno JM; Walsh CA; Struble CA; Livne O; Habib MI; Aharonovich E; Hasin DS
J Psychiatr Res; 2023 Jul; 163():211-221. PubMed ID: 37224773
[TBL] [Abstract][Full Text] [Related]
35. Psychosocial functioning among regular cannabis users with and without cannabis use disorder.
Foster KT; Arterberry BJ; Iacono WG; McGue M; Hicks BM
Psychol Med; 2018 Aug; 48(11):1853-1861. PubMed ID: 29173210
[TBL] [Abstract][Full Text] [Related]
36. Relationship of Cannabis Use Disorder and Irritable Bowel Syndrome (IBS): An Analysis of 6.8 Million Hospitalizations in the United States.
Patel RS; Goyal H; Satodiya R; Tankersley WE
Subst Use Misuse; 2020; 55(2):281-290. PubMed ID: 31573379
[No Abstract] [Full Text] [Related]
37. Quantity and frequency of cannabis use in relation to cannabis-use disorder and cannabis-related problems.
Callaghan RC; Sanches M; Kish SJ
Drug Alcohol Depend; 2020 Dec; 217():108271. PubMed ID: 32977043
[TBL] [Abstract][Full Text] [Related]
38. Cannabis Use and Disorder From Childhood to Adulthood in a Longitudinal Community Sample With American Indians.
Copeland WE; Hill S; Costello EJ; Shanahan L
J Am Acad Child Adolesc Psychiatry; 2017 Feb; 56(2):124-132.e2. PubMed ID: 28117058
[TBL] [Abstract][Full Text] [Related]
39. DSM-5 cannabis use disorder, substance use and DSM-5 specific substance-use disorders: Evaluating comorbidity in a population-based sample.
Hayley AC; Stough C; Downey LA
Eur Neuropsychopharmacol; 2017 Aug; 27(8):732-743. PubMed ID: 28663122
[TBL] [Abstract][Full Text] [Related]
40. Bipolar disorder and co-occurring cannabis use disorders: characteristics, co-morbidities and clinical correlates.
Lev-Ran S; Le Foll B; McKenzie K; George TP; Rehm J
Psychiatry Res; 2013 Oct; 209(3):459-65. PubMed ID: 23312479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
